Drug Database
Back to search

Canada· CA-DIN-02488361

TIBELLA

A tibolone product containing tibolone, registered in Canada by BIOSYENT PHARMA INC. The same ATC class is registered in 16 of our 19 countries.

ATC G03CX01

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedTIBELLAATCG03CX01REGISTER NO.CA-DIN-02488361PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tiboloneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tibolone is registered in 16 of 19 countries.

Countries holding a registration under ATC G03CX01 (tibolone), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 9 of them publish a price we can compare per daily dose
Search tibolone products by name

Tibolone · ATC G03CX01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tibolone costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.39 in Italy to $0.95 in Switzerland — a ×2.4 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tibolone · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.95
  • IT Italy$0.39
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
TIBOLONE
Manufacturer
BIOSYENT PHARMA INC
Country
Canada (CA)
ATC code
G03CX01
ATC class
Tibolone
Defined daily dose
2.5 mg, O
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tibolone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tibolone products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Liviel, Tiloria
  • Belgium · Heria, Livial
  • Bulgaria · Айвиал, Ливиал
  • Cyprus · Livial
  • Czechia · Ladybon, Livial
  • Germany · Liviella, Tibolon Aristo
  • Denmark · Livial, Tibocina
  • Spain · Boltin, Tibicare
  • Finland · Livial, Tibocina
  • France · Livial, Tibolone Ccd
  • United Kingdom (Northern Ireland) · Livial, Tibolone Aristo Pharma Gmbh
  • Greece · Juliette, Livial
  • Hungary · Ladybon, Livial
  • Ireland · Livial, Tibolone Aristo
  • Iceland · Livial
  • Italy · Livial, Menec
  • Lithuania · Livial
  • Luxembourg · Heria, Livial
  • Netherlands · Livial, Tibolinia
  • Norway · Livial, Tibocina
  • Poland · Ladybon, Livial
  • Portugal · Clitax, Goldar
  • Romania · Livial
  • Sweden · Livial, Tibelia
  • Slovenia · Livial
  • Slovakia · Ladybon, Livial

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1bb57343-36dd-4684-b6dd-732b50aff44c
GET /v1/drugs/1bb57343-36dd-4684-b6dd-732b50aff44c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02488361",
  "form": "TABLET",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "G03CX01",
  "schedule": [
    "Schedule G (CDSA IV)"
  ],
  "drug_code": "97847",
  "strengths": [
    "2.5 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "TIBOLONE"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about tibolone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console